ANGLE* (AGL): Interims; US FDA trial to start imminently (CORP) | Morses Club* (MCL): Accelerating growth on track (CORP) | Best of the Best* (BOTB): Interims comfortably on track (CORP) | PPHE Hotel Group* (PPH): Sales +19% and investing for the long term (CORP) | DiscoverIE* (DSCV): Continued strong growth and positive outlook (CORP)
31 Jan 2018
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
31 Jan 2018 -
Author:
Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
7
ANGLE* (AGL): Interims; US FDA trial to start imminently (CORP) | Morses Club* (MCL): Accelerating growth on track (CORP) | Best of the Best* (BOTB): Interims comfortably on track (CORP) | PPHE Hotel Group* (PPH): Sales +19% and investing for the long term (CORP) | DiscoverIE* (DSCV): Continued strong growth and positive outlook (CORP)